Mobile Site ›
Integration Through Community Laboratory Insourcing

Integration Through Community Laboratory Outreach


Responding to the Changing Health Care Environment

October 7-9, 2009
Hilton Orlando Bonnet Creek
Floridian Ballroom, Salon A
Orlando, Florida

Course Directors

Rodney W. Forsman
Administrative Director, Outcomes
Mayo Medical Laboratories
Assistant Professor of Laboratory Medicine
College of Medicine, Mayo Clinic
Rochester, Minnesota

Mayo Clinic Faculty

Richard O. Carlson
Systems Engineer
Mayo Medical Laboratories
Rochester, Minnesota

Joshua Derr
Manager
Mayo Clinic Health Policy Center
Mayo Clinic
Rochester, Minnesota

L. John Eckhart
Quality Management Coordinator
Department of Laboratory Medicine and Pathology
Mayo Clinic
Rochester, Minnesota

Tammy M.  Fletcher
Outreach Program Coordinator
Mayo Medical Laboratories
Rochester, Minnesota

Don R. Flott
Director of Learning and Development and Marketing Education
Mayo Collaborative Services, Inc.
Rochester, Minnesota

Jane Hermansen
Outreach Program Coordinator
Mayo Medical Laboratories
Rochester, Minnesota

Gretchen Johns, MD
Laboratory Director, Hematology and Coagulation
Department of Laboratory Medicine and Pathology
Senior Associate Consultant
Mayo Clinic
Jacksonville, Florida

David J. Priebe
Business Office Manager
Mayo Collaborative Services, Inc.
Rochester, Minnesota

Linda A. Spiten
Operations Administrator
Mayo Collaborative Services, Inc.
Rochester, Minnesota

Guest Faculty

Brenda Eriksen, MD
Medical Director
Community Hospital
Munster, Indiana

Charlene Harris
Director, Laboratory Services
Sarasota Memorial Hospital
Sarasota, Florida

Saralyn Hiley
Director of Outreach
Medical Center of Central Georgia
Macon, Georgia

Robert Stallone
Vice President, Laboratories
North Shore/Long Island Jewish Health System
Lake Success, New York

Faculty Disclosure

As a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo School of CME) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Thus, safeguards against commercial bias have been put in place. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so that participants in the activity may formulate their own judgments regarding the presentation.